BFM
MRNA icon

Boothbay Fund Management’s Moderna MRNA Stock Holding History

Boothbay Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,900
Closed -$462K – 2217
2025
Q3 		$462K Buy
+17,900
New +$499K 0.01% 1216
2025
Q2 		– Sell
-100,000
Closed -$2.83M – 1668
2025
Q1 		$2.83M Buy
+100,000
New +$3.55M 0.07% 353
2023
Q1 		– Sell
-35,600
Closed -$6.39M – 2380
2022
Q4 		$6.39M Buy
+35,600
New +$5.82M 0.15% 146
2021
Q2 		– Sell
-117
Closed -$1.53M – 2013
2021
Q1 		$1.53M Buy
+117
New +$17K 0.06% 419
2020
Q3 		– Sell
-38
Closed -$244K – 1143
2020
Q2 		$244K Buy
+38
New +$2.08K 0.02% 757

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Boothbay Fund Management's MRNA Position: Q2 2026 in Review

Boothbay Fund Management increased its Moderna (MRNA) stake by 79% in Q2 2026, buying an estimated $317K and bringing the position to 13,906 shares worth $974K. The position accounts for 0.01% of the portfolio, ranked #1112.

Boothbay Fund Management first reported a position in MRNA in Q4 2018 and has held it in 12 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Boothbay Fund Management held 13,906 shares of Moderna worth $974K as of Q2 2026.
  • Boothbay Fund Management bought 6,134 Moderna shares in Q2 2026, an estimated $317K.
  • Moderna made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1112 holding.
  • Boothbay Fund Management first reported a position in Moderna in Q4 2018 and has held it in 12 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.